Searched over 200M research papers
10 papers analyzed
These studies suggest metformin dosages for weight loss range from 1700 to 3000 mg/day, with effectiveness varying based on individual conditions such as age, body weight, and insulin resistance.
20 papers analyzed
Metformin, a widely used medication for type 2 diabetes, has also been explored for its potential in promoting weight loss in various populations, including those without diabetes. This article synthesizes findings from multiple studies to provide a comprehensive overview of the effective dosages and outcomes of metformin for weight loss.
A systematic review and network meta-analysis identified that for adolescents, a dosage of 2000 mg/day of metformin was more effective for weight loss compared to other interventions. However, a lower dose of 1000 mg/day for three months was also found to be suitable. For adults, the study highlighted that dosages of 3000 mg/day and 1000 mg/day were effective, with 3000 mg/day for six months and 1000 mg/day for 0.5 months being particularly suitable.
In obese women with polycystic ovary syndrome (PCOS), different doses of metformin (1500 mg and 2550 mg per day) were compared. Both doses resulted in significant weight loss, with the higher dose showing a slightly greater reduction in body weight. This suggests that higher doses may be more effective for weight loss in this subgroup.
A study on severely obese, insulin-resistant children aged 6-12 years found that a dosage of 1000 mg of metformin twice daily for six months led to significant decreases in BMI, body weight, and fat mass. This indicates that metformin can be effective in younger populations when administered at appropriate dosages.
In a trial comparing metformin to polyethylene glycol loxenatide (PEG-Loxe) in overweight or obese patients with type 2 diabetes, metformin at a dose of 1500 mg resulted in a weight loss of 2.96 kg over 16 weeks. Although PEG-Loxe showed greater weight loss, metformin still demonstrated significant efficacy.
A systematic review of metformin's efficacy over periods of six months or more found that both children and adults experienced weight loss with metformin treatment. In children, the weight reduction was more pronounced in the first six months, with no further significant improvements thereafter. In adults, metformin consistently led to small but significant weight reductions over longer durations.
Metformin's weight loss effects may be partly due to its ability to reduce food intake. A study on women with non-insulin-dependent diabetes mellitus (NIDDM) found that metformin decreased calorie intake and hunger ratings, with higher doses (1700 mg) having a more pronounced effect.
Metformin also improves insulin sensitivity, which can contribute to weight loss. This was observed in both children and adults, where improvements in insulin sensitivity were noted alongside reductions in body weight .
Metformin is an effective medication for weight loss across various populations, including adolescents, adults, and children with insulin resistance. Optimal dosages vary, with higher doses generally leading to greater weight loss. Metformin's mechanisms, including appetite suppression and improved insulin sensitivity, contribute to its efficacy. These findings support the use of metformin as a weight loss intervention, particularly in individuals with obesity and related metabolic conditions.
Most relevant research papers on this topic